Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Cantor Fitzgerald
Boehringer Ingelheim
US Army
Express Scripts
Cerilliant
US Department of Justice
Fish and Richardson

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RISEDRONATE SODIUM

« Back to Dashboard

Clinical Trials for Risedronate Sodium

Trial ID Title Status Sponsor Phase Summary
NCT00082277 Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer Completed AstraZeneca Phase 4 The purpose of this study is to evaluate safety parameters of anastrozole with regard to its potential effects on postmenopausal bone loss and on lipid profiles. This trial is conducted to investigate the effects of risedronate on BMD and on bone metabolism in postmenopausal women using anastrozole as adjuvant therapy for hormone-receptor-positive early breast cancer and who are high or moderate risk of fragility fracture. It is also conducted to determine the effects of anastrozole on bone mineral density (BMD) and on bone metabolism in women at low risk of fragility fracture.
NCT00447915 Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis Completed Chugai Pharmaceutical Phase 3 To evaluate the efficacy and safety of R484iv by intravenous intermittent administration to patients with primary osteoporosis in comparison with sodium risedronate hydrate (RIS) by oral administration every day. To evaluate also the dose response of R484iv.
NCT00452439 A Study of Actonel for the Prevention of Bone Loss Completed Procter and Gamble Phase 3 The goal of this clinical research study is to learn if Actonel (risedronate) can help to prevent the development of osteoporosis (brittle and weak bones) caused by the steroid medication used to treat leukemia. The safety of this treatment in patients with ALL or LL will also be studied.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Risedronate Sodium

Condition Name

Condition Name for Risedronate Sodium
Intervention Trials
Osteoporosis, Postmenopausal 2
Osteoporosis 2
Osteogenesis Imperfecta 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Risedronate Sodium
Intervention Trials
Osteoporosis 5
Fractures, Bone 2
Osteoporosis, Postmenopausal 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Risedronate Sodium

Trials by Country

Trials by Country for Risedronate Sodium
Location Trials
United States 9
Japan 4
United Kingdom 2
France 1
South Africa 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Risedronate Sodium
Location Trials
Texas 2
Pennsylvania 1
Ohio 1
North Carolina 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Risedronate Sodium

Clinical Trial Phase

Clinical Trial Phase for Risedronate Sodium
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Risedronate Sodium
Clinical Trial Phase Trials
Completed 7
Active, not recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Risedronate Sodium

Sponsor Name

Sponsor Name for Risedronate Sodium
Sponsor Trials
Procter and Gamble 3
Takeda 3
Sanofi 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Risedronate Sodium
Sponsor Trials
Industry 11
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Medtronic
McKinsey
US Army
Federal Trade Commission
Merck
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.